SCHEMBL4173091

SCHEMBL4173091

N#CC(=Cc1ccccc1Cl)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.50
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
ALDH1A1 P00352 4/20 0.42
LMNA P02545 3/20 0.42
HPGD P15428 3/20 0.42
KDM4E B2RXH2 2/20 0.42
RECQL P46063 1/20 0.42
ATM Q13315 2/20 0.41
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 2/20 0.39
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4173088 1.00 TRPA1 (0.50) TRPA1CA1CA2CA12CA9
SCHEMBL4173087 1.00 TRPA1 (0.50) TRPA1CA1CA2CA12CA9
SCHEMBL4182785 0.91 TRPA1 (0.47) TRPA1CA1CA2CA12CA9
SCHEMBL4171782 0.91 TRPA1 (0.47) TRPA1CA1CA2CA12CA9
SCHEMBL4171775 0.91 TRPA1 (0.47) TRPA1CA1CA2CA12CA9
SCHEMBL4171778 0.91 TRPA1 (0.47) TRPA1CA1CA2CA12CA9
SCHEMBL4182792 0.91 TRPA1 (0.47) TRPA1CA1CA2CA12CA9
SCHEMBL4182790 0.91 TRPA1 (0.47) TRPA1CA1CA2CA12CA9
SCHEMBL4179281 0.84 ALDH1A1 (0.43) CA1CA2CA12CA9ALDH1A1
SCHEMBL4179284 0.84 ALDH1A1 (0.43) CA1CA2CA12CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 TRPA1 3599/4885CA1 3291/4885CA2 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.